Frontier Science #19 - Chemoproteomics w/ Dan Nomura - Professor @ UC Berkeley | BIOS

Guest: Dan Nomura is a Professor of Chemical Biology and Molecular Therapeutics in the Department of Chemistry, Department of Molecular and Cell Biology in the Division of Molecular Therapeutics, and the Department of Nutritional Sciences and Toxicology at the University of California, Berkeley and an Investigator at the Innovative Genomics Institute. He is also an Adjunct Professor in the Department of Pharmaceutical Chemistry at UCSF. Since 2017, he has also been the Director of the Novartis-Berkeley Translational Chemical Biology Institute focused on using chemoproteomic platforms to tackle the undruggable proteome. He is also Co-Founder of Frontier Medicines, a start-up company focused on using chemoproteomics and machine learning approaches to tackle the undruggable proteome. He is also the Founder of Vicinitas Therapeutics based on his group’s discovery of the Deubiquitinase Targeting Chimera (DUBTAC) platform for targeted protein stabilization. He is also on the Scientific Advisory Committee for the Mark Foundation for Cancer Research. He earned his B.A. in Molecular and Cell Biology and Ph.D. in Molecular Toxicology at UC Berkeley with Professor John Casida and was a postdoctoral fellow at Scripps Research with Professor Benjamin F. Cravatt before returning to Berkeley as a faculty member in 2011. Among his honors include the National Cancer Institute Outstanding Investigator Award, Searle Scholar, American Cancer Society Research Scholar Award, and the Mark Foundation for Cancer Research ASPIRE award.

_______________________

Join BIOS Community 🎉
Become a member, continue the conversation, connect with like-minded Life Science innovators, access exclusive resources, & invite-only events…

Apply to Join —https://docs.google.com/forms/d/e/1FA...

For More Interesting Content 💭

🦾 Website: https://www.bios.community/
🧬 Podcast: https://open.spotify.com/show/2HmcPq9...
🧪 Medium:   / bios  
🩺 Twitter:   / bios_community  
🦠 LinkedIn:   / bios-community  
🧠 Substack: https://bioscommunity.substack.com

_______________________

BIOS: Nucleus of Life Science Innovation 🚀

Alix Ventures: Driving Patient Impact - Supporting Early Stage Startups Engineering Biology to Create Radical Advances in Human Health🌟